The 36-month beta value for APDN is at 0.09. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for APDN is 14.89M, and currently, shorts hold a 1.75% of that float. The average trading volume for APDN on April 05, 2024 was 109.22K shares.
APDN) stock’s latest price update
Applied Dna Sciences Inc (NASDAQ: APDN)’s stock price has decreased by -9.48 compared to its previous closing price of 0.44. However, the company has seen a -6.52% decrease in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-02-21 that Here is how Applied DNA Sciences (APDN) and Encore Wire (WIRE) have performed compared to their sector so far this year.
APDN’s Market Performance
APDN’s stock has fallen by -6.52% in the past week, with a monthly drop of -29.81% and a quarterly drop of -36.39%. The volatility ratio for the week is 10.43% while the volatility levels for the last 30 days are 13.05% for Applied Dna Sciences Inc The simple moving average for the last 20 days is -14.69% for APDN stock, with a simple moving average of -58.35% for the last 200 days.
Analysts’ Opinion of APDN
Many brokerage firms have already submitted their reports for APDN stocks, with ROTH Capital repeating the rating for APDN by listing it as a “Buy.” The predicted price for APDN in the upcoming period, according to ROTH Capital is $24 based on the research report published on February 12, 2021 of the previous year 2021.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see APDN reach a price target of $14, previously predicting the price at $18. The rating they have provided for APDN stocks is “Buy” according to the report published on January 14th, 2021.
H.C. Wainwright gave a rating of “Buy” to APDN, setting the target price at $12 in the report published on December 18th of the previous year.
APDN Trading at -27.32% from the 50-Day Moving Average
After a stumble in the market that brought APDN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.49% of loss for the given period.
Volatility was left at 13.05%, however, over the last 30 days, the volatility rate increased by 10.43%, as shares sank -28.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -36.38% lower at present.
During the last 5 trading sessions, APDN fell by -6.52%, which changed the moving average for the period of 200-days by -70.80% in comparison to the 20-day moving average, which settled at $0.4609. In addition, Applied Dna Sciences Inc saw -35.13% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for APDN
Current profitability levels for the company are sitting at:
- -1.5 for the present operating margin
- 0.38 for the gross margin
The net margin for Applied Dna Sciences Inc stands at -0.81. The total capital return value is set at -1.85. Equity return is now at value -107.64, with -47.72 for asset returns.
Based on Applied Dna Sciences Inc (APDN), the company’s capital structure generated 0.21 points at debt to capital in total, while cash flow to debt ratio is standing at -6.8. The debt to equity ratio resting at 0.26. The interest coverage ratio of the stock is 2.57.
Currently, EBITDA for the company is -10.45 million with net debt to EBITDA at 0.12. When we switch over and look at the enterprise to sales, we see a ratio of 0.51. The receivables turnover for the company is 19.96for trailing twelve months and the total asset turnover is 0.91. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.77.
Conclusion
In conclusion, Applied Dna Sciences Inc (APDN) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
